This page lists all pharmaceutical reports related to the field of Cardiovascular Disorders. The reports include market research reports and pipeline analyses.
- Biomarkers: A Market Briefing
- Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Medical Imaging Markets: Radiography
- The Global Market for Adjunctive Therapies in Cancer
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- Diabetes and Diabetic Complications: Major World Markets
- Nitric Oxide - Therapeutics, Markets and Companies
- Cardiovascular Drug Delivery - technologies,markets and companies
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Stem Cell Markets
- Hematology Analyzer Instrumentation and Reagent Markets
- The World Hypertension Market 2005-2010
- Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- The Cardiovascular Market Outlook to 2011
- Early Toxicology: Markets and Approaches
- Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Antithrombotics - Pipeline products to dampen the impact of patent expiries and cost containment initiatives
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
- Antihypertensives - New challenges for a maturing market
- From Blockbuster to Nichebuster
- Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Pipeline Insight: Antihypertensives - Weak pipeline leaves innovation to Novartis
- Pulmonary Arterial Hypertension - A small market gets big attention
- Drug Treatment in End-Stage Renal Disease
- Therapeutic Vaccines
- Antihypertensives - Two Years to Shape the Market?
- Hypertension - Multiple Layers of Therapy Cover all Eventualities
- Chronic and Acute Heart Failure
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
- Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
- Stakeholder Insight: Heart Failure
- Stakeholder Insight: Acute Stroke
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Pipeline Insight: Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Drug Discovery Tools for High-Content Analysis
- Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
- Personalized Medicine
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
- ANEMIA - Therapy Area Pipeline Report
- HEMOPHILIA OR BLOOD COAGULATION DISORDERS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- Critical Limb Ischemia-US Epidemiology
- ANGINA - Therapy Area Pipeline Report
- ARRHYTHMIAS - Therapy Area Pipeline Report
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- CONGESTIVE HEART FAILURE - Therapy Area Pipeline Report
- EDEMA - Therapy Area Pipeline Report
- HYPERTENSION - Therapy Area Pipeline Report
- INTERMITTENT CLAUDICATION - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- MYOCARDIAL INFARCTION - Therapy Area Pipeline Report
- PERIPHERAL VASCULAR DISEASE - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- THROMBOEMBOLISM - Therapy Area Pipeline Report
- THROMBOSIS - Therapy Area Pipeline Report
- Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- The World Cardiovascular Drug Market: Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents
- Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters
- Commercial Insight: Antithrombotics - Market expands as disease management focuses on prevention
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The World Hypertension Market 2007-2023
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Ventricular Fibrillation and Atrial Fibrillation
- Diabetic Nephropathy - Prevalence and Therapeutic Potential
- 2003 Cardiovascular Market Update
- Thrombosis in Cancer - Expanding Focus for Anticoagulants
- Stakeholder Insight: Atrial Fibrillation - Future Advances in Stroke Prevention
- Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Player
- Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fail
- Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
- The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
- The Cardiovascular Market Outlook to 2008
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- New Anticoagulant Therapies: A Market Briefing
- Cardiovascular Disease: The 45+ Market in the United States for Drugs and Medical Devices
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline perspectives: Peripheral artery disease Poor disease awareness hinders new agents
- How to Conduct Clinical Trials in China
- The Anti-Migraine Market 2007-2022
- Congestive Heart Failure: Major World Markets - Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
- Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture
- Launching Combination Products: Brand extension and franchise development strategies
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- Peripheral arterial disease: New pharmaceutical therapies to treat intermittent claudication symptoms, prevent ischemic events and to induce angiogenesis
- PAD Interventional Market Analysis: Angioplasty and Atherectomy
- PAD Interventional Market Analysis: Primary and Provisional Stenting
- PAD Interventional Market:Perioperative Oral Antiplatelet Therapy
- Acute Limb Ischemia - A market of multiple therapies and multiple procedures
- Peripheral Arterial Disease: A Significant Opportunity for Interventional Therapies
- Peripheral Arterial Disease: Significant Opportunity for Drug Therapies
- The Cardiovascular Disorders Market Outlook to 2012
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Congestive Heart Failure: Major World Markets - Pharmaceutical Management
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Percutaneous Coronary Intervention
- Heart Failure - Therapeutic Options
